|
Status |
Public on Mar 05, 2013 |
Title |
MLN4924 in chronic lymphocytic leukemia |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
CLL cells obtained from patients with CLL were treated with MLN4924 to determine whether NFkB transcription targets were affected by the drug.
|
|
|
Overall design |
CLL cells were treated with 1 microM MLN4924 or vehicle control for 24 hours. Cells were collected by centrifugation and B-cell were purified using negative selection (B cell purification Kit, Multenyi Biotech). RNA was isolated and submitted for Gene expression analysis
|
|
|
Contributor(s) |
Danilov A |
Citation(s) |
24634471 |
|
Submission date |
Mar 05, 2013 |
Last update date |
Aug 13, 2018 |
Contact name |
Alexey Danilov |
Organization name |
Oregon Health and Science Univeristy
|
Street address |
3181 SW Sam Jackson Pk Rd
|
City |
Portland |
State/province |
OR |
ZIP/Postal code |
97219 |
Country |
USA |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (22)
|
|
Relations |
BioProject |
PRJNA192430 |